Merck & CompanyvsSBC Medical Group

MRK and SBC stock compared: price, dividend, valuation and results, from SEC filings.

MRK

Merck & Company, Inc.

$146.63

Value $363B

-0.76%
MRK's page

SBC

SBC Medical Group Holdings Incorporated

$6.58

Value $675M

-10.48%
SBC's page

Merck & Company (MRK) has a market value of $363B and SBC Medical Group (SBC) $675M. Over the last year, with dividends, MRK moved +62.5% and SBC +98.8%. The P/E is 147.8 for MRK and 13.0 for SBC. Dividend yield: MRK 2.32%, SBC none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    MRK$363B

    SBC$675M

    MRK is 537 times SBC

  • Revenue, 12 months

    MRK$67.4B

    SBC$190M

    MRK is 354 times SBC

  • Net income, 12 months

    MRK$2.5B

    SBC$52M

    MRK is 47 times SBC

  • Operating margin

    MRK–

    SBC39.9%

  • ROIC

    MRK3.9%

    SBC16.3%

    12.4 points apart

  • P/E

    MRK147.8

    SBC13.0

    MRK is 11 times SBC

  • Dividend yield

    MRK2.3%

    SBC0.0%

    2.3 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

MRK+57.6%

SBC-38.2%

50100150202420252026
Returns by period
PeriodMRKWith dividendsSBCWith dividends
1 year since November 14, 2025+62.5%Price +57.8%+98.8%Price +98.8%
3 years since November 16, 2023+57.6%+16.4% a yearPrice +43.8%-38.2%-14.8% a yearPrice -38.2%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

MRKMerck & CompanySBCSBC Medical Group

Valuation

MRKSBC
Valuation
Price$146.63$6.58
Market value$363B$675M
Enterprise value (EV)$407B$519M
P/E147.813.0
P/E, 5-year median14.811.6
P/B8.12.4
EV/EBIT85.46.8
Free cash flow yield4.1%14.9%

Results and growth

MRKSBC
Results and growth
Revenue, 12 months$67.4B$190M
Net income, 12 months$2.5B$52M
Free cash flow, 12 months$14.7B$100M
Earnings per share, 12 months$0.98$0.50
Revenue growth, year on year1.3%-15.5%
Revenue growth a year, past+9.4%over 5 years-5.3%over 2 years
EPS growth a year, past+21.2%over 5 years+9.1%over 2 years

Margins and returns on capital

MRKSBC
Margins and returns on capital
Gross margin71.8%72.2%
Operating margin–39.9%
Net margin3.6%27.3%
ROIC3.9%16.3%
ROE5.2%19.9%

Balance sheet

MRKSBC
Balance sheet
Cash$9.7B$199M
Total debt$53.8B$53M
Net debt / EBITDA5.7-2.0
Interest cover2.4×181.9×

Dividends and buybacks

MRKSBC
Dividends and buybacks
Dividend yield2.3%–
Dividend per share, 12 months$3.40–
Dividend growth a year, past+5.8%over 5 years–
Buyback yield1.4%0.7%
Shareholder yield3.7%0.7%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: MRK or SBC

Didn't find what you were looking for?

Ask us
Which is bigger, Merck & Company or SBC Medical Group?

By market value, Merck & Company ($363B) is about 537.1 times SBC Medical Group ($675M), at today's prices.

How did MRK and SBC stock do over the last 3 years?

Since November 16, 2023, MRK's price moved +43.8% and SBC's -38.2%. With dividends: MRK +57.6% (+16.4% a year), SBC -38.2% (-14.8% a year). Past returns do not predict future ones.

Which pays the higher dividend, MRK or SBC?

The dividend yield at today's price is 2.32% for Merck & Company and none for SBC Medical Group. Over the last twelve months they paid $3.40 and – per share.

What is the P/E of MRK and SBC?

At today's price, the P/E is 147.8 for MRK and 13.0 for SBC. The median of the last five years was 14.8 and 11.6, which shows where each stands against its own past.

Which has the higher profit margins, Merck & Company or SBC Medical Group?

Over the last twelve months, the net margin was 3.6% for Merck & Company and 27.3% for SBC Medical Group, and the operating margin – and 39.9%. Revenue was $67.4B and $190M.

Which is the better investment, Merck & Company or SBC Medical Group?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.